Alterity Therapeutics Ltd
ATHE- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001131343
In the last 90 days, Alterity Therapeutics Ltd insiders filed 1 open-market purchase and 0 sales; 21 institutions reported holding it in 13F filings for Q2 2026, worth $2.12M in total; no superinvestor holds it.
Other share classesPRNAF
Q3 2025 vs. Q2 2025
How the institutions holding Alterity Therapeutics Ltd changed between Q2 2025 and Q3 2025.
All holders in Q3 2025All holders in Q2 2025
| Measure | Q2 2025 | Q3 2025 | Change |
|---|---|---|---|
| Holders | 11 | 16 | +5 |
| Shares | 221.8K | 334.6K | +112.8K (+50.8%) |
| Value | $906.9K | $1.26M | +$351.6K (+38.8%) |
New holders (6)
Institutions that held Alterity Therapeutics Ltd at the end of Q3 2025 but not at the end of Q2 2025.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| HB Wealth Management, LLC | 58,460 | $219.8K | 0.00% |
| Citadel Advisors LLC | 22,144 | $83.5K | 0.00% |
| Acadian Asset Management LLC | 4,799 | $18.0K | 0.00% |
| Citigroup Inc | 636 | $2.40K | 0.00% |
| Farther Finance Advisors, LLC | 22 | $83 | 0.00% |
| SBI Securities Co., Ltd. | 1 | $4 | 0.00% |
Sold out (1)
Institutions that held Alterity Therapeutics Ltd at the end of Q2 2025 and filed for Q3 2025 without it.
| Institution | Shares, Q2 2025 | Value, Q2 2025 |
|---|---|---|
| Point72 Asset Management, L.P. | 131,431 | $537.3K |